Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
Authors
Keywords
-
Journal
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-24
DOI
10.1016/j.drudis.2021.02.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ASK1/p38‑mediated NLRP3 inflammasome signaling pathway contributes to aberrant retinal angiogenesis in diabetic retinopathy
- (2020) Wenjun Zou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model
- (2019) Wei He et al. Journal of Neuroinflammation
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- MCC950 closes the active conformation of NLRP3 to an inactive state
- (2019) Ana Tapia-Abellán et al. Nature Chemical Biology
- NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia
- (2019) Rebecca Ward et al. PHARMACOLOGICAL RESEARCH
- RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux
- (2019) Leandro Silva da Costa et al. Cell Death & Disease
- ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells
- (2019) Di Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo
- (2019) He-Qi Bu et al. OncoTargets and Therapy
- Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury
- (2019) Mónica B. Jiménez-Castro et al. Cells
- A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
- (2019) CongXiao Zhang et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP 3 inflammasome activation via the inhibition of AMPK / mTOR ‐mediated autophagy induction
- (2019) Qi Wang et al. IMMUNOLOGY AND CELL BIOLOGY
- Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases
- (2019) Xiangna Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways
- (2018) Jushuang Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology
- (2018) Yoshiki Kojo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice
- (2018) Yadong Zhai et al. MOLECULES
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice
- (2018) Pu Hong et al. NEURAL PLASTICITY
- Microglia and CNS Interleukin-1: Beyond Immunological Concepts
- (2018) Xiaoyu Liu et al. Frontiers in Neurology
- Evidence against a role for NLRP3-driven islet inflammation in db/db mice
- (2018) H.L. Kammoun et al. Molecular Metabolism
- NLRP3 inflammasome in colitis and colitis-associated colorectal cancer
- (2018) Agampodi Promoda Perera et al. MAMMALIAN GENOME
- New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
- (2018) Zhenyu Zhong et al. NATURE
- Damage-Associated Molecular Patterns in Inflammatory Diseases
- (2018) Jong Seong Roh et al. Immune Network
- NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis
- (2018) Nicole Ranson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
- (2018) Congfei Xu et al. Nature Communications
- Inflammasomes and type 2 diabetes: An updated systematic review
- (2017) Zahra Sepehri et al. IMMUNOLOGY LETTERS
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
- (2017) Renqing Wang et al. LABORATORY INVESTIGATION
- Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
- (2017) Melvin Kantono et al. Frontiers in Immunology
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- Understanding migraine: Potential role of neurogenic inflammation
- (2016) Rakesh Malhotra Annals of Indian Academy of Neurology
- Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway
- (2016) Hong-Qian Chu et al. DIGESTIVE AND LIVER DISEASE
- Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells
- (2016) Hong Wang et al. EXPERIMENTAL CELL RESEARCH
- Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B
- (2016) Qian Qian Liu et al. Journal of Digestive Diseases
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950
- (2016) Manohar Salla et al. ACS Medicinal Chemistry Letters
- TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells
- (2016) Hisa Hui Ling Tseng et al. Scientific Reports
- NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis
- (2016) Shigehiro Itani et al. Scientific Reports
- Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
- (2015) A. Abderrazak et al. CIRCULATION
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adipose Tissue Inflammation in the Pathogenesis of Type 2 Diabetes
- (2015) Ayano Kohlgruber et al. Current Diabetes Reports
- Miro1-mediated mitochondrial dysfunction under high nutrient stress is linked to NOD-like receptor 3 (NLRP3)-dependent inflammatory responses in rat pancreatic beta cells
- (2015) Jianfeng Gao et al. FREE RADICAL BIOLOGY AND MEDICINE
- NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients
- (2015) Sonja Johann et al. GLIA
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
- (2015) Jonathan L. Schmid-Burgk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Oridonin's therapeutic effect: Suppressing Th1/Th17 simultaneously in a mouse model of Crohn's disease
- (2015) Shubei Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Regulation of NOD-like receptors and inflammasome activation in cerebral endothelial cells
- (2015) Péter Nagyőszi et al. JOURNAL OF NEUROCHEMISTRY
- Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
- (2015) O J Harrison et al. Mucosal Immunology
- Colorectal cancer
- (2015) Herb Brody NATURE
- NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
- (2015) Hexin Shi et al. NATURE IMMUNOLOGY
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components
- (2015) Rongrong Liu et al. Oncotarget
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases
- (2015) Amna Abderrazak et al. Redox Biology
- Chemical stimulation of the intracranial dura activates NALP3 inflammasome in trigeminal ganglia neurons
- (2014) Lingzhi Chen et al. BRAIN RESEARCH
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Localization and Functionality of the Inflammasome in Neutrophils
- (2014) Martina Bakele et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine
- (2014) Flóra Gölöncsér et al. JOURNAL OF HEADACHE AND PAIN
- Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function
- (2014) M. G. Ghonime et al. JOURNAL OF IMMUNOLOGY
- Inflammasome activation has an important role in the development of spontaneous colitis
- (2014) J Zhang et al. Mucosal Immunology
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- Oridonin Attenuates Aβ1–42-Induced Neuroinflammation and Inhibits NF-κB Pathway
- (2014) Sulei Wang et al. PLoS One
- Inflammatory bowel disease: Pathogenesis
- (2014) Yi-Zhen Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis
- (2014) Eun Ran Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation
- (2013) E. D. Hottz et al. BLOOD
- Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection
- (2013) Youssef Aachoui et al. CURRENT OPINION IN MICROBIOLOGY
- Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
- (2013) Shankar S. Iyer et al. IMMUNITY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome
- (2013) Yuan He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
- (2013) Ryan W. Grant et al. Frontiers in Immunology
- NLRP3 Suppresses NK Cell-Mediated Responses to Carcinogen-Induced Tumors and Metastases
- (2012) M. T. Chow et al. CANCER RESEARCH
- Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer
- (2012) Jonas Ungerbäck et al. CARCINOGENESIS
- TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria
- (2012) Vijay A.K. Rathinam et al. CELL
- Thioredoxin-Interacting Protein Mediates ER Stress-Induced β Cell Death through Initiation of the Inflammasome
- (2012) Christine M. Oslowski et al. Cell Metabolism
- IRE1α Induces Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote Programmed Cell Death under Irremediable ER Stress
- (2012) Alana G. Lerner et al. Cell Metabolism
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Protective and Aggravating Effects of Nlrp3 Inflammasome Activation in IBD Models: Influence of Genetic and Environmental Factors
- (2012) Christian Bauer et al. DIGESTIVE DISEASES
- Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells
- (2012) FENG-HOU GAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Toll or Interleukin-1 Receptor (TIR) Domain-containing Adaptor Inducing Interferon-β (TRIF)-mediated Caspase-11 Protease Production Integrates Toll-like Receptor 4 (TLR4) Protein- and Nlrp3 Inflammasome-mediated Host Defense against Enteropathogens
- (2012) Prajwal Gurung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+Th17 cells
- (2012) Margherita Coccia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
- (2012) Geun-Shik Lee et al. NATURE
- A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?
- (2012) Haitao Wen et al. NATURE IMMUNOLOGY
- Sensing and reacting to microbes through the inflammasomes
- (2012) Luigi Franchi et al. NATURE IMMUNOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation
- (2011) Bo Hu et al. CELL CYCLE
- Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
- (2011) Yun-Hee Youm et al. ENDOCRINOLOGY
- IL-1 and IL-1 Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
- (2011) P. Rider et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
- (2011) Haitao Wen et al. NATURE IMMUNOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Inflammasome is a central player in the induction of obesity and insulin resistance
- (2011) R. Stienstra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Nlrp3 inflammasome: contributions to intestinal homeostasis
- (2011) Md. Hasan Zaki et al. TRENDS IN IMMUNOLOGY
- The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice
- (2010) N Shiota et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
- (2010) C. Bauer et al. GUT
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
- (2010) Md. Hasan Zaki et al. IMMUNITY
- Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases
- (2010) Jeremy Dupaul-Chicoine et al. IMMUNITY
- NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
- (2010) Simon A. Hirota et al. INFLAMMATORY BOWEL DISEASES
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Downregulation of AP-1 gene expression is an initial event in the oridonin-mediated inhibition of colorectal cancer: Studies in vitro and in vivo
- (2010) Heiying Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
- (2010) M. H. Zaki et al. JOURNAL OF IMMUNOLOGY
- Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance
- (2010) H. Yang et al. JOURNAL OF IMMUNOLOGY
- Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia
- (2010) M. Lamkanfi et al. JOURNAL OF IMMUNOLOGY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy
- (2010) S. M. Tan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
- (2010) B. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic strategies by modulating oxygen stress in cancer and inflammation
- (2009) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Cutting Edge: TNF- Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation
- (2009) L. Franchi et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Activation of the Nlrp3 Inflammasome by Streptococcus pyogenes Requires Streptolysin O and NF- B Activation but Proceeds Independently of TLR Signaling and P2X7 Receptor
- (2009) J. Harder et al. JOURNAL OF IMMUNOLOGY
- Cholesterol-dependent cytolysins induce rapid release of mature IL-1β from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner
- (2009) Jessica Chu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1
- (2009) Xiaomei Sun et al. PATHOLOGY INTERNATIONAL
- Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal
- (2009) Catherine Dostert et al. PLoS One
- Thioredoxin-Interacting Protein: A Critical Link Between Glucose Toxicity and -Cell Apoptosis
- (2008) J. Chen et al. DIABETES
- Tranilast Inhibits Glucose-induced Insulin Secretion from Pancreatic β-Cells
- (2008) S. Taguchi et al. HORMONE AND METABOLIC RESEARCH
- Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects1
- (2008) G. P. Lambert JOURNAL OF ANIMAL SCIENCE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1 and IL-18 secretion in an autocrine way
- (2008) A. Piccini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis
- (2008) Chad K Heazlewood et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started